Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:57:20.146Z.
Calculation as of: 2026-10-06T14:57:20.146Z.
Quote observation: 2026-10-06T14:55:05.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e4c5e5530b5f4ff9b2ae64c4564a307684e7c74323ce66c5db527ab157f5d0a0
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
IceCure Medical Ltd
Market Cap
$3.28M
Operating Cash Flow Yield
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD |
|---|---|---|
| IceCure Medical Ltd (ICCM) | $3.28M | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.25M | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.27M | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.21M | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.40M | N/A |
| Evogene Ltd. (EVGN)vs › | $3.46M | N/A |
| Eocene Ltd. (EOCN)vs › | $3.47M | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.58M | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
